{"gene":"OPN1MW","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":1986,"finding":"OPN1MW (green cone opsin) gene was isolated and sequenced from the human X chromosome (Xq28), revealing it is arranged in a head-to-tail tandem array with the red opsin gene. The deduced amino acid sequence shows 96% identity with red opsin and 43% identity with blue opsin, establishing the molecular basis of human trichromatic color vision.","method":"Genomic and cDNA cloning, DNA sequencing, Southern blotting","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — original molecular cloning and sequencing study, foundational and widely replicated","pmids":["2937147"],"is_preprint":false},{"year":1983,"finding":"The green cone photoreceptor (M-cone) visual pigment was characterized by microspectrophotometry, establishing an absorption maximum of approximately 530.8 nm (with evidence for a bimodal sub-population distribution at ~533.7 and ~527.8 nm) in human foveal and parafoveal retina.","method":"Microspectrophotometry of human cone outer segments","journal":"Proceedings of the Royal Society of London. Series B","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro spectroscopic measurement of photopigment absorption in isolated human photoreceptors","pmids":["6140680"],"is_preprint":false},{"year":1989,"finding":"A fusion gene derived from recombination between OPN1LW and OPN1MW was sequenced and its encoded photopigment characterized spectroscopically; the pigment encoded by this hybrid gene absorbed light similar to normal M-cone (green) pigment (~530 nm) despite containing coding sequence from both genes, directly linking gene structure to pigment spectral properties.","method":"DNA sequencing of fusion gene, pigment spectroscopy","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — direct correlation of gene sequence with measured spectral properties of expressed pigment","pmids":["2574415"],"is_preprint":false},{"year":1994,"finding":"The spectral difference (31 nm) between human red (OPN1LW) and green (OPN1MW) cone opsins is determined by exactly 7 amino acid residues (positions 116, 180, 230, 233, 277, 285, and 309), identified through an extensive mutagenesis study of 28 chimeric proteins and 30 point mutants. Replacing these residues converts red-to-green pigment spectral properties.","method":"Site-directed mutagenesis, expression of chimeric and point-mutant opsins, spectroscopic characterization","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis and spectroscopic validation, large systematic study","pmids":["8185948"],"is_preprint":false},{"year":1996,"finding":"RanBP2, a large cyclophilin-related protein (containing Ran-binding domain 4 [RBD4] and cyclophilin domains), acts as a molecular chaperone specifically for red/green (L/M) opsin in cone photoreceptors. The cyclophilin domain augments and stabilizes the interaction between red/green opsin and RBD4, possibly via proline isomerization, but does not bind opsin directly.","method":"Biochemical binding assays, domain dissection, functional chaperone assays in Drosophila/vertebrate systems","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 — identification of binding partner with mechanistic follow-up (domain dissection, cyclophilin activity), replicated across systems","pmids":["8857542"],"is_preprint":false},{"year":1998,"finding":"The human green cone pigment (OPN1MW) was functionally expressed in large-scale Sf9 insect cell cultures using recombinant baculovirus and purified via immobilized metal affinity chromatography. The purified pigment activated rod G-protein transducin at about half the rate of rhodopsin. Photo-intermediate analysis (Meta I, Meta II, Meta III) revealed the Meta I–Meta II equilibrium lacks pH dependence (unlike rod pigment), and the rate of Meta II decay was significantly faster than in rhodopsin.","method":"Recombinant expression in Sf9 cells, immobilized metal affinity chromatography purification, UV-Vis spectroscopy, G-protein activation assay, lipid reconstitution","journal":"The Biochemical Journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with functional assay and spectroscopic characterization of photo-intermediates","pmids":["9494086"],"is_preprint":false},{"year":1999,"finding":"The position of a green-red hybrid gene within the OPN1LW/OPN1MW tandem array determines color vision phenotype: the hybrid gene causes deuteranomaly only when it occupies the second position (where it is expressed), and does not cause color vision defects when it is in the third or more distal position (where it is not expressed). mRNA expression analysis confirmed position-dependent expression.","method":"Long-range PCR, gene sequencing, mRNA expression analysis in post-mortem retinae","journal":"Nature Genetics","confidence":"High","confidence_rationale":"Tier 2 — direct demonstration of position-dependent gene expression from post-mortem human retinae, consistent with clinical phenotyping","pmids":["10319869"],"is_preprint":false},{"year":2003,"finding":"GRK1 (G protein-coupled receptor kinase 1) phosphorylates light-activated M-cone opsin (OPN1MW) at multiple sites in a light-dependent manner in mouse retina. Following phosphorylation, cone arrestin (mCAR) binds to the phosphorylated, light-activated M-cone opsin, quenching phototransduction. In Nrl−/−Grk1−/− double-knockout mice, cone opsins are neither phosphorylated nor bound by cone arrestin.","method":"In situ phosphorylation, isoelectric focusing, immunoprecipitation with cone opsin and cone arrestin antibodies, genetic knockout mouse models","journal":"The Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — reciprocal immunoprecipitation, confirmed by genetic epistasis (double KO), multiple orthogonal methods","pmids":["12853434"],"is_preprint":false},{"year":2009,"finding":"11-cis-retinol acts as an inverse agonist on expressed human green cone opsin (OPN1MW), inactivating its constitutive activity (measured as transducin activation). It also promotes pigment formation (chromophore binding) in salamander cone photoreceptors, supporting a distinct retinoid handling mechanism in cones compared to rods.","method":"Cell-free transducin activation assay (GTPγS incorporation), microspectrophotometry of isolated photoreceptors, comparative pharmacology","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution assay with expressed opsin, confirmed by microspectrophotometry in isolated photoreceptors","pmids":["19386593"],"is_preprint":false},{"year":2002,"finding":"Three novel missense mutations in OPN1MW (Asn94Lys) and OPN1LW (Arg330Gln, Gly338Glu) cause red/green color vision deficiencies by disrupting visual pigment formation: Asn94Lys and Gly338Glu mutations abolish all detectable absorbance (loss of pigment), while Arg330Gln yields a low-absorbance pigment with λmax of 530 nm, indicating these mutations impair protein folding required for chromophore binding.","method":"Mutation identification by DNA sequencing, expression of mutant opsins in COS-7 cells, reconstitution with 11-cis-retinal, UV-Vis spectrophotometry","journal":"Biochemical and Biophysical Research Communications","confidence":"High","confidence_rationale":"Tier 1 — expression and spectroscopic characterization of mutant opsins with defined functional consequences","pmids":["12051694"],"is_preprint":false},{"year":1992,"finding":"A missense mutation in OPN1MW (C203R, cysteine to arginine at position 203) causes severe deuteranomaly (green color vision deficiency). This conserved cysteine is necessary for normal green opsin function, presumably for correct protein folding.","method":"DNA sequencing, clinical color vision phenotyping","journal":"Nature Genetics","confidence":"Medium","confidence_rationale":"Tier 2 — direct mutation identification with clinical phenotypic consequence, but mechanistic basis inferred rather than directly tested in vitro","pmids":["1302020"],"is_preprint":false},{"year":2010,"finding":"The W177R missense mutation affecting OPN1MW (arising by gene conversion making both opsin genes identical to the MW sequence) causes protein misfolding and retention in the endoplasmic reticulum, leading to X-linked cone dystrophy. Unlike the P23H rod opsin mutation, W177R misfolding is not rescued by pharmacological chaperone 9-cis-retinal.","method":"Molecular genetic analysis, cell-based expression with ER localization assay, pharmacological chaperone treatment assay","journal":"American Journal of Human Genetics","confidence":"High","confidence_rationale":"Tier 2 — cellular mechanistic assay (ER retention) combined with pharmacological chaperone rescue experiment, clear molecular mechanism established","pmids":["20579627"],"is_preprint":false},{"year":2015,"finding":"Human green cone opsin (OPN1MW) and red cone opsin (OPN1LW) adopt different transient conformations during chromophore regeneration: photoactivated green cone opsin regenerates via an unprotonated Schiff base intermediate, whereas red cone opsin forms a typical protonated Schiff base. Site-directed mutagenesis and molecular modeling identified structural differences in the photoactivated state between the two pigments.","method":"UV-Vis and fluorescence spectroscopy, site-directed mutagenesis, molecular modeling","journal":"Cellular and Molecular Life Sciences","confidence":"Medium","confidence_rationale":"Tier 1-2 — in vitro spectroscopic and mutagenesis study with molecular modeling, single lab","pmids":["26387074"],"is_preprint":false},{"year":2016,"finding":"Human red cone opsin (OPN1LW) exhibits a strong propensity for dimerization via a specific interface in the fifth transmembrane helix involving residues I230, A233, and M236, identified by mutagenesis. Green cone opsin (OPN1MW) does not dimerize strongly. Notably, the same residues (I230, A233) responsible for red opsin dimerization are also partially responsible for spectral tuning differences between red and green opsins.","method":"Time-resolved fluorescence (measuring dimerization affinity), site-directed mutagenesis, spectroscopic analysis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1-2 — biophysical measurement of dimerization with mutagenesis confirmation and functional (spectral tuning) link, multiple orthogonal methods","pmids":["28045251"],"is_preprint":false},{"year":2019,"finding":"Human red and green cone opsins (OPN1LW and OPN1MW) are O-glycosylated at a conserved N-terminal Ser/Thr-rich domain (at Ser22 in bovine OPSR) in addition to N-glycosylation at Asn34. This O-glycosylation is conserved across vertebrates (mammals, birds, amphibians), as demonstrated by jacalin lectin binding, O-glycosidase treatment revealing the underlying epitope, and mass spectrometry identifying O-glycan on Ser22.","method":"Monoclonal antibody recognition assay, O-glycosidase treatment, jacalin lectin binding, mass spectrometry, cross-species analysis","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (antibody, lectin, MS, enzymatic treatment) identifying post-translational modification in native human retinal tissue","pmids":["30948514"],"is_preprint":false},{"year":2021,"finding":"Specific exon 3 haplotypes of OPN1MW (e.g., 'LIAVA', 'LVAVA') cause exon 3 skipping during pre-mRNA splicing, abolishing or severely reducing correctly spliced transcripts, leading to vision disorders including Blue Cone Monochromacy. Intrachromosomal gene conversion between OPN1LW and OPN1MW in the male germline was demonstrated to generate pathogenic haplotypes de novo (e.g., 'LIAVA' from ancestral 'LIAVS').","method":"Semi-quantitative minigene splicing assay, molecular haplotyping, pedigree analysis demonstrating de novo gene conversion","journal":"Genes","confidence":"High","confidence_rationale":"Tier 1-2 — functional splicing assay with multiple haplotypes tested, combined with pedigree-level demonstration of gene conversion mechanism","pmids":["34440353","27339364"],"is_preprint":false},{"year":2018,"finding":"AAV5-mediated subretinal delivery of human OPN1MW or OPN1LW into Opn1mw−/− mice (M-opsin knockout model of Blue Cone Monochromacy) promotes regrowth of cone outer segments in the dorsal retina and rescues M-cone-mediated ERG function. Both M- and L-opsin constructs are effective, and rescue is maintained for at least 13 months post-injection.","method":"Subretinal AAV5 gene delivery, electroretinography (ERG), immunohistochemistry, western blotting","journal":"Molecular Vision","confidence":"High","confidence_rationale":"Tier 2 — in vivo gene therapy rescue experiment with multiple functional and structural readouts","pmids":["29386880"],"is_preprint":false},{"year":2019,"finding":"AAV5-mediated L-opsin gene therapy can rescue M-cone function and outer segment structure in aged Opn1mw−/− mice (up to 15 months old), demonstrating that the remaining viable cones retain the capacity to respond to opsin gene delivery even at advanced age, though cone outer segment degeneration begins early and ventral S-opsin-dominant cones remain normal.","method":"Subretinal AAV5 injection, electroretinography, PNA staining for cone quantification, immunohistochemistry","journal":"Investigative Ophthalmology & Visual Science","confidence":"High","confidence_rationale":"Tier 2 — in vivo gene therapy with functional and structural outcomes across multiple ages","pmids":["31469404"],"is_preprint":false},{"year":2022,"finding":"Gene augmentation therapy with AAV-mediated human L-opsin delivery rescues cone outer segment structure and function in Opn1mw−/− mice (lacking both M- and S-opsin, a more stringent BCM model), but only when delivered at 2 months of age or younger; therapeutic efficacy is significantly reduced at 5–7 months. Impaired proteasomal activity was excluded as a contributing stress factor in cone degeneration.","method":"Subretinal AAV injection, ERG, immunohistochemistry, crossing with proteasomal reporter mouse (UbG76V-GFP)","journal":"Human Gene Therapy","confidence":"High","confidence_rationale":"Tier 2 — in vivo gene therapy with defined therapeutic window and mechanistic exclusion experiment","pmids":["35272502"],"is_preprint":false}],"current_model":"OPN1MW encodes the human M-cone (green) visual pigment, a GPCR localized in cone outer segments whose 530 nm absorption maximum is determined by 7 specific amino acid residues differentiating it from red opsin; after light activation, it is phosphorylated by GRK1 and bound by cone arrestin to terminate phototransduction, undergoes regeneration via an unprotonated Schiff base intermediate (distinct from red opsin), is O-glycosylated at a conserved N-terminal Ser/Thr domain, is chaperoned by the RanBP2 cyclophilin domain for proper folding, and pathogenic exon 3 haplotypes or missense mutations (e.g., W177R causing ER retention, C203R, Asn94Lys) that disrupt splicing or protein folding cause a spectrum of color vision deficiency to progressive cone dystrophy, which can be rescued in mouse models by AAV-mediated opsin gene delivery."},"narrative":{"teleology":[{"year":1983,"claim":"Before the gene was cloned, the spectral identity of the M-cone pigment was established by directly measuring an ~530 nm absorption maximum in human foveal cone outer segments, defining the physical property that OPN1MW must encode.","evidence":"Microspectrophotometry of isolated human cone photoreceptors","pmids":["6140680"],"confidence":"High","gaps":["Bimodal sub-population (527.8 vs 533.7 nm) not fully explained","Molecular basis of spectral tuning unknown at this stage"]},{"year":1986,"claim":"Cloning OPN1MW from Xq28 revealed its tandem arrangement with OPN1LW and 96% amino acid identity, establishing the molecular genetic basis of green–red color discrimination and explaining the high frequency of recombination-driven color vision defects.","evidence":"Genomic/cDNA cloning and sequencing, Southern blotting","pmids":["2937147"],"confidence":"High","gaps":["Which specific residues drive spectral tuning not yet identified","Expression regulation within the tandem array unknown"]},{"year":1989,"claim":"Characterization of a naturally occurring OPN1LW–OPN1MW fusion gene showed that hybrid gene structure directly determines pigment spectral properties, providing the first genotype-to-phenotype link for color vision variation.","evidence":"DNA sequencing of fusion gene combined with pigment spectroscopy","pmids":["2574415"],"confidence":"High","gaps":["Individual spectral-tuning residues not resolved"]},{"year":1992,"claim":"Identification of the C203R missense mutation as a cause of severe deuteranomaly established that a single residue change in OPN1MW is sufficient to abolish green cone function, implicating a conserved disulfide bond in protein folding.","evidence":"DNA sequencing with clinical color vision phenotyping in affected individuals","pmids":["1302020"],"confidence":"Medium","gaps":["No in vitro expression or spectroscopic confirmation of C203R at this stage","Mechanism of folding defect inferred from conservation rather than demonstrated"]},{"year":1994,"claim":"Systematic mutagenesis resolved the spectral tuning code to exactly seven amino acid positions, answering a decade-long question about which residues account for the 31 nm red–green shift and enabling prediction of hybrid gene phenotypes.","evidence":"28 chimeric and 30 point-mutant opsins expressed and characterized by UV-Vis spectroscopy","pmids":["8185948"],"confidence":"High","gaps":["Structural mechanism by which each residue shifts absorption not determined","In vivo validation of all positions not performed"]},{"year":1996,"claim":"Discovery that the RanBP2 cyclophilin domain acts as a specific molecular chaperone for L/M opsins revealed a post-translational folding requirement unique to cone pigments and explained why mutations disrupting folding are particularly pathogenic.","evidence":"Biochemical binding assays and domain dissection across Drosophila and vertebrate systems","pmids":["8857542"],"confidence":"High","gaps":["Whether RanBP2 chaperoning involves proline isomerization in vivo unresolved","Stoichiometry and kinetics of the chaperone interaction unknown"]},{"year":1998,"claim":"Purification and functional reconstitution of recombinant OPN1MW demonstrated that it activates transducin at roughly half the rate of rhodopsin and exhibits distinct photo-intermediate kinetics (pH-independent Meta I–Meta II equilibrium, faster Meta II decay), establishing core differences between cone and rod signaling.","evidence":"Baculovirus expression in Sf9 cells, affinity purification, UV-Vis spectroscopy, GTPγS-based transducin activation assay","pmids":["9494086"],"confidence":"High","gaps":["Lipid-dependence of photo-intermediate kinetics not fully characterized","Comparison to OPN1LW under identical conditions not reported"]},{"year":1999,"claim":"Position-dependent expression within the tandem array was demonstrated: only the first or second gene copy is transcribed, explaining why the same hybrid gene causes deuteranomaly in one array position but is phenotypically silent in more distal positions.","evidence":"Long-range PCR with mRNA expression analysis in post-mortem human retinae","pmids":["10319869"],"confidence":"High","gaps":["Locus control region mechanism not fully elucidated","Whether position-dependence is absolute or probabilistic unclear"]},{"year":2002,"claim":"Functional expression of disease-associated missense mutants (Asn94Lys in OPN1MW; Arg330Gln, Gly338Glu in OPN1LW) demonstrated that color vision deficiency can arise from complete loss of chromophore binding due to misfolding, not only from spectral shifts.","evidence":"Expression in COS-7 cells, reconstitution with 11-cis-retinal, UV-Vis spectrophotometry","pmids":["12051694"],"confidence":"High","gaps":["Folding intermediate trapped by each mutation not characterized","Whether pharmacological rescue is possible not tested"]},{"year":2003,"claim":"Demonstration that GRK1 phosphorylates light-activated M-cone opsin and that cone arrestin binds the phosphorylated pigment established the canonical desensitization pathway for M-cones, paralleling but distinct from the rod cascade.","evidence":"In situ phosphorylation, isoelectric focusing, immunoprecipitation in Nrl−/−Grk1−/− double-knockout mice","pmids":["12853434"],"confidence":"High","gaps":["Exact phosphorylation sites on OPN1MW not mapped","Whether GRK7 contributes in human cones not addressed"]},{"year":2009,"claim":"11-cis-retinol was shown to act as an inverse agonist of OPN1MW, suppressing constitutive transducin activation and promoting chromophore binding in cones, revealing a retinoid-handling mechanism absent in rods.","evidence":"Cell-free GTPγS incorporation assay with expressed green opsin, microspectrophotometry of salamander cones","pmids":["19386593"],"confidence":"High","gaps":["Physiological relevance of inverse agonism in intact human cones not demonstrated","Source and trafficking of 11-cis-retinol in the cone-Müller cell cycle not resolved"]},{"year":2010,"claim":"The W177R mutation was shown to cause ER retention and misfolding-driven cone dystrophy that is refractory to 9-cis-retinal pharmacological chaperone rescue, distinguishing this pathogenic mechanism from the rescuable P23H rhodopsin mutation and highlighting the severity of M-opsin folding mutations.","evidence":"Cell-based expression with ER localization and pharmacological chaperone rescue assays","pmids":["20579627"],"confidence":"High","gaps":["Structural basis for why W177R is unrescuable not determined","Whether other chaperone strategies could rescue W177R untested"]},{"year":2015,"claim":"Discovery that OPN1MW regenerates via an unprotonated Schiff base intermediate, unlike OPN1LW which uses a protonated intermediate, identified a fundamental mechanistic difference between the two highly similar cone pigments and implicated specific structural divergences in the photoactivated state.","evidence":"UV-Vis and fluorescence spectroscopy, site-directed mutagenesis, molecular modeling","pmids":["26387074"],"confidence":"Medium","gaps":["Single-lab observation not yet independently confirmed","Crystal or cryo-EM structure of the intermediate not available"]},{"year":2016,"claim":"Biophysical measurement showed OPN1MW has weak dimerization propensity compared to OPN1LW, and the dimerization interface residues (I230, A233, M236 in TM5) overlap with spectral-tuning sites, linking oligomerization state to spectral identity.","evidence":"Time-resolved fluorescence measuring dimerization affinity, site-directed mutagenesis","pmids":["28045251"],"confidence":"High","gaps":["In vivo oligomeric state in cone outer segments not known","Functional consequence of differing dimerization propensity on phototransduction not tested"]},{"year":2016,"claim":"Functional splicing assays established that specific exon 3 haplotypes (LIAVA, LVAVA) in OPN1MW cause exon 3 skipping, and pedigree analysis demonstrated that intrachromosomal gene conversion generates these pathogenic haplotypes de novo, providing a molecular mechanism for recurrent Blue Cone Monochromacy.","evidence":"Semi-quantitative minigene splicing assay, molecular haplotyping, pedigree analysis","pmids":["34440353","27339364"],"confidence":"High","gaps":["Splicing regulatory elements mediating exon 3 skipping not identified","Frequency of de novo gene conversion events in population not quantified"]},{"year":2018,"claim":"AAV5-mediated delivery of human M- or L-opsin into M-opsin knockout mice rescued cone outer segment regrowth and ERG function for at least 13 months, providing the first proof-of-concept for gene therapy of Blue Cone Monochromacy.","evidence":"Subretinal AAV5 injection, ERG, immunohistochemistry, western blotting in Opn1mw−/− mice","pmids":["29386880"],"confidence":"High","gaps":["Optimal therapeutic window not defined","Translation to primate retina not yet demonstrated"]},{"year":2019,"claim":"O-glycosylation at a conserved N-terminal Ser/Thr domain was identified on human L/M opsins, revealing a previously unrecognized post-translational modification conserved across vertebrates whose functional role remains unknown.","evidence":"Monoclonal antibody recognition, O-glycosidase treatment, jacalin lectin binding, mass spectrometry on native human retina","pmids":["30948514"],"confidence":"High","gaps":["Functional role of O-glycosylation in opsin trafficking or stability not determined","Glycosyltransferase responsible not identified"]},{"year":2022,"claim":"A critical therapeutic window was defined: AAV-mediated opsin gene therapy rescues M-cone structure and function only when delivered by 2 months in Opn1mw−/− mice, with efficacy declining sharply thereafter, indicating that cone degeneration becomes irreversible and is not driven by proteasomal stress.","evidence":"Subretinal AAV injection at multiple ages, ERG, immunohistochemistry, proteasomal reporter mouse cross","pmids":["35272502"],"confidence":"High","gaps":["Mechanism of irreversible cone loss beyond the window not identified","Whether human cones have a comparably narrow window unknown"]},{"year":null,"claim":"Key unresolved questions include the high-resolution structure of OPN1MW (and its photo-intermediates), the functional significance of O-glycosylation and differential dimerization, the identity of splicing regulatory elements governing exon 3 inclusion, and the translational therapeutic window for gene therapy in human Blue Cone Monochromacy patients.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal or cryo-EM structure of OPN1MW","O-glycosylation function uncharacterized","Therapeutic window in primate/human retina undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,3,5,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[8]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,11]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[11]}],"pathway":[{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[1,3,5,7,8]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,7,8]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[9,10,11,15]}],"complexes":[],"partners":["GRK1","ARR3","RANBP2","GNAT2","OPN1LW"],"other_free_text":[]},"mechanistic_narrative":"OPN1MW encodes the medium-wave-sensitive (green) cone opsin, a G protein-coupled receptor that initiates phototransduction in M-cones with an absorption maximum near 530 nm, underpinning trichromatic color vision [PMID:6140680, PMID:2937147]. The spectral difference between OPN1MW and the red opsin OPN1LW is determined by seven amino acid residues (positions 116, 180, 230, 233, 277, 285, 309), and OPN1MW is distinguished biophysically by regeneration through an unprotonated Schiff base intermediate, faster Meta II decay, and weak dimerization propensity [PMID:8185948, PMID:26387074, PMID:28045251, PMID:9494086]. Light-activated OPN1MW is phosphorylated by GRK1 and subsequently bound by cone arrestin to terminate signaling, is chaperoned by the RanBP2 cyclophilin domain for proper folding, and carries a conserved O-glycosylation at an N-terminal Ser/Thr domain [PMID:12853434, PMID:8857542, PMID:30948514]. Pathogenic exon 3 haplotypes (e.g., LIAVA/LVAVA) cause exon-skipping and Blue Cone Monochromacy, while missense mutations such as W177R cause ER retention and progressive cone dystrophy; AAV-mediated opsin gene delivery rescues cone structure and function in M-opsin knockout mouse models [PMID:34440353, PMID:20579627, PMID:29386880]."},"prefetch_data":{"uniprot":{"accession":"P04001","full_name":"Medium-wave-sensitive opsin 1","aliases":["Green cone photoreceptor pigment","Green-sensitive opsin","GOP"],"length_aa":364,"mass_kda":40.6,"function":"Visual pigments are the light-absorbing molecules that mediate vision. They consist of an apoprotein, opsin, covalently linked to cis-retinal","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P04001/entry"},"depmap":{"release":"DepMap","has_data":false,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/OPN1MW"},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/OPN1MW","total_profiled":1310},"omim":[{"mim_id":"611028","title":"TRANSMEMBRANE PROTEIN 30A; TMEM30A","url":"https://www.omim.org/entry/611028"},{"mim_id":"608845","title":"ADP-RIBOSYLATION FACTOR-LIKE GTPase 6; ARL6","url":"https://www.omim.org/entry/608845"},{"mim_id":"303800","title":"COLORBLINDNESS, PARTIAL, DEUTAN SERIES; CBD","url":"https://www.omim.org/entry/303800"},{"mim_id":"303700","title":"BLUE CONE MONOCHROMACY; BCM","url":"https://www.omim.org/entry/303700"},{"mim_id":"300824","title":"OPN1LW AND OPN1MW GENES, CONTROLLER OF","url":"https://www.omim.org/entry/300824"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"retina","ntpm":12.6}],"url":"https://www.proteinatlas.org/search/OPN1MW"},"hgnc":{"alias_symbol":["OPN1MW1","COD5"],"prev_symbol":["GCP","CBBM","CBD"]},"alphafold":{"accession":"P04001","domains":[{"cath_id":"1.20.1070.10","chopping":"52-338","consensus_level":"medium","plddt":91.2426,"start":52,"end":338}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P04001","model_url":"https://alphafold.ebi.ac.uk/files/AF-P04001-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P04001-F1-predicted_aligned_error_v6.png","plddt_mean":82.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=OPN1MW","jax_strain_url":"https://www.jax.org/strain/search?query=OPN1MW"},"sequence":{"accession":"P04001","fasta_url":"https://rest.uniprot.org/uniprotkb/P04001.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P04001/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P04001"}},"corpus_meta":[{"pmid":"25703248","id":"PMC_25703248","title":"Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.","date":"2015","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25703248","citation_count":397,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16378099","id":"PMC_16378099","title":"GCP-WD is a gamma-tubulin targeting factor required for centrosomal and chromatin-mediated microtubule nucleation.","date":"2005","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16378099","citation_count":269,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25666611","id":"PMC_25666611","title":"Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD).","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25666611","citation_count":251,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35083862","id":"PMC_35083862","title":"A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).","date":"2022","source":"Basic & clinical pharmacology & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/35083862","citation_count":193,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33169541","id":"PMC_33169541","title":"Diversity of molecular targets and signaling pathways for CBD.","date":"2020","source":"Pharmacology research & perspectives","url":"https://pubmed.ncbi.nlm.nih.gov/33169541","citation_count":187,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17197447","id":"PMC_17197447","title":"Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17197447","citation_count":175,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32053110","id":"PMC_32053110","title":"The proposed mechanisms of action of CBD in epilepsy.","date":"2020","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/32053110","citation_count":152,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15652347","id":"PMC_15652347","title":"GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors.","date":"2005","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/15652347","citation_count":141,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30150937","id":"PMC_30150937","title":"Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer.","date":"2018","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30150937","citation_count":117,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12591113","id":"PMC_12591113","title":"Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells.","date":"2003","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12591113","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33521943","id":"PMC_33521943","title":"A new Cannabis genome assembly associates elevated cannabidiol (CBD) with hemp introgressed into marijuana.","date":"2021","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/33521943","citation_count":107,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12533683","id":"PMC_12533683","title":"The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with interleukin-8/CXCL8.","date":"2003","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12533683","citation_count":85,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29450258","id":"PMC_29450258","title":"The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation.","date":"2018","source":"Cannabis and cannabinoid research","url":"https://pubmed.ncbi.nlm.nih.gov/29450258","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31811927","id":"PMC_31811927","title":"CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer.","date":"2019","source":"International journal of pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/31811927","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22818914","id":"PMC_22818914","title":"Nek9 phosphorylation of NEDD1/GCP-WD contributes to Plk1 control of γ-tubulin recruitment to the mitotic centrosome.","date":"2012","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/22818914","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35741337","id":"PMC_35741337","title":"Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review.","date":"2022","source":"Biology","url":"https://pubmed.ncbi.nlm.nih.gov/35741337","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15214047","id":"PMC_15214047","title":"CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue.","date":"2004","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15214047","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15297432","id":"PMC_15297432","title":"A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.","date":"2004","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/15297432","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18443119","id":"PMC_18443119","title":"The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial.","date":"2008","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/18443119","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22304711","id":"PMC_22304711","title":"The role of glutamate signaling in pain processes and its regulation by GCP II inhibition.","date":"2012","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22304711","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21243485","id":"PMC_21243485","title":"Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews.","date":"2011","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21243485","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35667235","id":"PMC_35667235","title":"Extracellular vesicles of cannabis with high CBD content induce anticancer signaling in human hepatocellular carcinoma.","date":"2022","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/35667235","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29784129","id":"PMC_29784129","title":"The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice.","date":"2018","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29784129","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15988615","id":"PMC_15988615","title":"Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study.","date":"2005","source":"Sleep & breathing = Schlaf & Atmung","url":"https://pubmed.ncbi.nlm.nih.gov/15988615","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21236563","id":"PMC_21236563","title":"Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis.","date":"2011","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/21236563","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33604949","id":"PMC_33604949","title":"CBD activation of TRPV1 induces oxidative signaling and subsequent ER stress in breast cancer cell lines.","date":"2021","source":"Biotechnology and applied biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33604949","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33113776","id":"PMC_33113776","title":"A Critical Review of the Role of the Cannabinoid Compounds Δ9-Tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment.","date":"2020","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/33113776","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35631242","id":"PMC_35631242","title":"Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue.","date":"2022","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/35631242","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33096116","id":"PMC_33096116","title":"Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP/PS1 Alzheimer's mice uncovered by RNA-seq.","date":"2020","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33096116","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8588741","id":"PMC_8588741","title":"Expression of the cbbLcbbS and cbbM genes and distinct organization of the cbb Calvin cycle structural genes of Rhodobacter capsulatus.","date":"1995","source":"Archives of microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/8588741","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32348868","id":"PMC_32348868","title":"CBD modulates DNA methylation in the prefrontal cortex and hippocampus of mice exposed to forced swim.","date":"2020","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/32348868","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35658956","id":"PMC_35658956","title":"Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claim.","date":"2022","source":"Journal of cannabis research","url":"https://pubmed.ncbi.nlm.nih.gov/35658956","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33583102","id":"PMC_33583102","title":"Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies.","date":"2021","source":"Pharmacotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/33583102","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12629525","id":"PMC_12629525","title":"Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA.","date":"2002","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12629525","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22525263","id":"PMC_22525263","title":"Synthesis of galactooligosaccharides by CBD fusion β-galactosidase immobilized on cellulose.","date":"2012","source":"Bioresource technology","url":"https://pubmed.ncbi.nlm.nih.gov/22525263","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27865421","id":"PMC_27865421","title":"Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation.","date":"2016","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27865421","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37088127","id":"PMC_37088127","title":"Review of the oral toxicity of cannabidiol (CBD).","date":"2023","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/37088127","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35455470","id":"PMC_35455470","title":"Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice.","date":"2022","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35455470","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36015263","id":"PMC_36015263","title":"Fabrication and Preliminary In Vitro Evaluation of 3D-Printed Alginate Films with Cannabidiol (CBD) and Cannabigerol (CBG) Nanoparticles for Potential Wound-Healing Applications.","date":"2022","source":"Pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/36015263","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30796934","id":"PMC_30796934","title":"DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptor.","date":"2019","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30796934","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34630100","id":"PMC_34630100","title":"CBD Alleviates Liver Injuries in Alcoholics With High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome-Pyroptosis Pathway.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34630100","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35892693","id":"PMC_35892693","title":"Differential Effects of D9 Tetrahydrocannabinol (THC)- and Cannabidiol (CBD)-Based Cannabinoid Treatments on Macrophage Immune Function In Vitro and on Gastrointestinal Inflammation in a Murine Model.","date":"2022","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/35892693","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18842116","id":"PMC_18842116","title":"Granulocyte chemotactic protein 2 (gcp-2/cxcl6) complements interleukin-8 in periodontal disease.","date":"2008","source":"Journal of periodontal research","url":"https://pubmed.ncbi.nlm.nih.gov/18842116","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25438942","id":"PMC_25438942","title":"GCP-WD mediates γ-TuRC recruitment and the geometry of microtubule nucleation in interphase arrays of Arabidopsis.","date":"2014","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/25438942","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34289379","id":"PMC_34289379","title":"Effects of cannabinoid (CBD) on blood brain barrier permeability after brain injury in rats.","date":"2021","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/34289379","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35535052","id":"PMC_35535052","title":"The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne.","date":"2022","source":"Journal of inflammation research","url":"https://pubmed.ncbi.nlm.nih.gov/35535052","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17827342","id":"PMC_17827342","title":"Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells.","date":"2007","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/17827342","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27339364","id":"PMC_27339364","title":"De novo intrachromosomal gene conversion from OPN1MW to OPN1LW in the male germline results in Blue Cone Monochromacy.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27339364","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32221778","id":"PMC_32221778","title":"Developmental exposure to cannabidiol (CBD) alters longevity and health span of zebrafish (Danio rerio).","date":"2020","source":"GeroScience","url":"https://pubmed.ncbi.nlm.nih.gov/32221778","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34564578","id":"PMC_34564578","title":"Effect of Cannabidiol (CBD) on Canine Inflammatory Response: An Ex Vivo Study on LPS Stimulated Whole Blood.","date":"2021","source":"Veterinary sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34564578","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32144889","id":"PMC_32144889","title":"Cautious Hope for Cannabidiol (CBD) in Rheumatology Care.","date":"2023","source":"Arthritis care & research","url":"https://pubmed.ncbi.nlm.nih.gov/32144889","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18809212","id":"PMC_18809212","title":"Constitutive expression of the antibacterial CXC chemokine GCP-2/CXCL6 by epithelial cells of the male reproductive tract.","date":"2008","source":"Journal of reproductive immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18809212","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18956592","id":"PMC_18956592","title":"Neutrophil chemokines GCP-2 and GRO-alpha in patients with inflammatory bowel disease.","date":"2008","source":"Journal of digestive diseases","url":"https://pubmed.ncbi.nlm.nih.gov/18956592","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23494274","id":"PMC_23494274","title":"Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine.","date":"2013","source":"Analytical and bioanalytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23494274","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32928411","id":"PMC_32928411","title":"Conversion of cannabidiol (CBD) to Δ9-tetrahydrocannabinol (Δ9-THC) during protein precipitations prior to plasma samples analysis by chromatography - Troubles with reliable CBD quantitation when acidic precipitation agents are applied.","date":"2020","source":"Talanta","url":"https://pubmed.ncbi.nlm.nih.gov/32928411","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25993443","id":"PMC_25993443","title":"The neutrophil-recruiting chemokine GCP-2/CXCL6 is expressed in cystic fibrosis airways and retains its functional properties after binding to extracellular DNA.","date":"2015","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25993443","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34440353","id":"PMC_34440353","title":"Intermixing the OPN1LW and OPN1MW Genes Disrupts the Exonic Splicing Code Causing an Array of Vision Disorders.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34440353","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38191853","id":"PMC_38191853","title":"The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD.","date":"2024","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/38191853","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37433966","id":"PMC_37433966","title":"Fetal cannabidiol (CBD) exposure alters thermal pain sensitivity, problem-solving, and prefrontal cortex excitability.","date":"2023","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/37433966","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32410387","id":"PMC_32410387","title":"Guanidiniocarbonyl-Pyrroles (GCP) - 20 Years of the Schmuck Binding Motif.","date":"2020","source":"ChemPlusChem","url":"https://pubmed.ncbi.nlm.nih.gov/32410387","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11483010","id":"PMC_11483010","title":"Cloning, expression, and purification of the Staphylococcus simulans lysostaphin using the intein-chitin-binding domain (CBD) system.","date":"2001","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/11483010","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35009133","id":"PMC_35009133","title":"THC and CBD Fingerprinting of an Elite Cannabis Collection from Iran: Quantifying Diversity to Underpin Future Cannabis Breeding.","date":"2022","source":"Plants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35009133","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37147420","id":"PMC_37147420","title":"Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37147420","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34445602","id":"PMC_34445602","title":"Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34445602","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17330234","id":"PMC_17330234","title":"Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD-HepII polypeptide of fibronectin.","date":"2007","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17330234","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26633906","id":"PMC_26633906","title":"Loss of γ-tubulin, GCP-WD/NEDD1 and CDK5RAP2 from the Centrosome of Neurons in Developing Mouse Cerebral and Cerebellar Cortex.","date":"2015","source":"Acta histochemica et cytochemica","url":"https://pubmed.ncbi.nlm.nih.gov/26633906","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35229949","id":"PMC_35229949","title":"CBD-mediated regulation of heroin withdrawal-induced behavioural and molecular changes in mice.","date":"2022","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/35229949","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35644678","id":"PMC_35644678","title":"THC and CBD affect metabolic syndrome parameters including microbiome in mice fed high fat-cholesterol diet.","date":"2022","source":"Journal of cannabis research","url":"https://pubmed.ncbi.nlm.nih.gov/35644678","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30796258","id":"PMC_30796258","title":"Identification of the first endolysin Cell Binding Domain (CBD) targeting Paenibacillus larvae.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30796258","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36626330","id":"PMC_36626330","title":"Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD).","date":"2023","source":"Chemical research in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/36626330","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35651623","id":"PMC_35651623","title":"High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35651623","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34790210","id":"PMC_34790210","title":"Production of Feminized Seeds of High CBD Cannabis sativa L. by Manipulation of Sex Expression and Its Application to Breeding.","date":"2021","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/34790210","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39377785","id":"PMC_39377785","title":"Mannose-Functionalized Chitosan-Coated PLGA Nanoparticles for Brain-Targeted Codelivery of CBD and BDNF for the Treatment of Alzheimer's Disease.","date":"2024","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/39377785","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36292998","id":"PMC_36292998","title":"The Protective Effect of CBD in a Model of In Vitro Ischemia May Be Mediated by Agonism on TRPV2 Channel and Microglia Activation.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36292998","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22703237","id":"PMC_22703237","title":"Evidence of form II RubisCO (cbbM) in a perennially ice-covered Antarctic lake.","date":"2012","source":"FEMS microbiology ecology","url":"https://pubmed.ncbi.nlm.nih.gov/22703237","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31680972","id":"PMC_31680972","title":"2-APB and CBD-Mediated Targeting of Charged Cytotoxic Compounds Into Tumor Cells Suggests the Involvement of TRPV2 Channels.","date":"2019","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31680972","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37863344","id":"PMC_37863344","title":"Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms.","date":"2023","source":"The journal of pain","url":"https://pubmed.ncbi.nlm.nih.gov/37863344","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33887676","id":"PMC_33887676","title":"Chronic cannabidiol (CBD) administration induces anticonvulsant and antiepileptogenic effects in a genetic model of epilepsy.","date":"2021","source":"Epilepsy & behavior : E&B","url":"https://pubmed.ncbi.nlm.nih.gov/33887676","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31469404","id":"PMC_31469404","title":"Rescue of M-cone Function in Aged Opn1mw-/- Mice, a Model for Late-Stage Blue Cone Monochromacy.","date":"2019","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/31469404","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32019055","id":"PMC_32019055","title":"Potency Assessment of CBD Oils by Their Effects on Cell Signaling Pathways.","date":"2020","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/32019055","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35277472","id":"PMC_35277472","title":"New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts.","date":"2022","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/35277472","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23056478","id":"PMC_23056478","title":"The essentiality of staphylococcal Gcp is independent of its repression of branched-chain amino acids biosynthesis.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23056478","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34676344","id":"PMC_34676344","title":"Cannabidiol (CBD) Oil Does Not Display an Entourage Effect in Reducing Cancer Cell Viability in vitro.","date":"2020","source":"Medical cannabis and cannabinoids","url":"https://pubmed.ncbi.nlm.nih.gov/34676344","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36351915","id":"PMC_36351915","title":"Diagnostic analysis of the highly complex OPN1LW/OPN1MW gene cluster using long-read sequencing and MLPA.","date":"2022","source":"NPJ genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36351915","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38333615","id":"PMC_38333615","title":"Construction of functional neural network tissue combining CBD-NT3-modified linear-ordered collagen scaffold and TrkC-modified iPSC-derived neural stem cells for spinal cord injury repair.","date":"2024","source":"Bioactive materials","url":"https://pubmed.ncbi.nlm.nih.gov/38333615","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32623021","id":"PMC_32623021","title":"THC and CBD produce divergent effects on perception and panic behaviours via distinct cortical molecular pathways.","date":"2020","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/32623021","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39778776","id":"PMC_39778776","title":"CBD and the 5-HT1A receptor: A medicinal and pharmacological review.","date":"2025","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39778776","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31802588","id":"PMC_31802588","title":"Effects of O-1602 and CBD on TNBS-induced colonic disturbances.","date":"2019","source":"Neurogastroenterology and motility","url":"https://pubmed.ncbi.nlm.nih.gov/31802588","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34638139","id":"PMC_34638139","title":"Activity of THC, CBD, and CBN on Human ACE2 and SARS-CoV1/2 Main Protease to Understand Antiviral Defense Mechanism.","date":"2021","source":"Planta medica","url":"https://pubmed.ncbi.nlm.nih.gov/34638139","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37287996","id":"PMC_37287996","title":"Hair Regrowth with Cannabidiol (CBD)-rich Hemp Extract - A Case Series.","date":"2021","source":"Cannabis (Albuquerque, N.M.)","url":"https://pubmed.ncbi.nlm.nih.gov/37287996","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34306025","id":"PMC_34306025","title":"Genomic and Chemical Diversity of Commercially Available High-CBD Industrial Hemp Accessions.","date":"2021","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34306025","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36557613","id":"PMC_36557613","title":"Cannabis sativa CBD Extract Exhibits Synergy with Broad-Spectrum Antibiotics against Salmonella enterica subsp. Enterica serovar typhimurium.","date":"2022","source":"Microorganisms","url":"https://pubmed.ncbi.nlm.nih.gov/36557613","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39093319","id":"PMC_39093319","title":"Efficacy of anti-seizure medications and alternative therapies (ketogenic diet, CBD, and quinidine) in KCNT1-related epilepsy: A systematic review.","date":"2024","source":"Epilepsia open","url":"https://pubmed.ncbi.nlm.nih.gov/39093319","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22212659","id":"PMC_22212659","title":"Distribution and phylogenetic diversity of cbbM genes encoding RubisCO form II in a deep-sea hydrothermal field revealed by newly designed PCR primers.","date":"2012","source":"Extremophiles : life under extreme conditions","url":"https://pubmed.ncbi.nlm.nih.gov/22212659","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36078578","id":"PMC_36078578","title":"Cannabidiol (CBD) Protects Adipose-Derived Mesenchymal Stem Cells (ASCs) against Endoplasmic Reticulum Stress Development and Its Complications.","date":"2022","source":"International journal of environmental research and public health","url":"https://pubmed.ncbi.nlm.nih.gov/36078578","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36633803","id":"PMC_36633803","title":"Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis).","date":"2023","source":"Current treatment options in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36633803","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19394691","id":"PMC_19394691","title":"GCP, a genistein-rich compound, inhibits proliferation and induces apoptosis in lymphoma cell lines.","date":"2009","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/19394691","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7776828","id":"PMC_7776828","title":"The design, synthesis and testing of desoxy-CBD: further evidence for a region of steric interference at the cannabinoid receptor.","date":"1995","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/7776828","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33989997","id":"PMC_33989997","title":"Discrimination of CBD-, THC- and CBC-type acid cannabinoids through diagnostic ions by UHPLC-HR-MS/MS in negative ion mode.","date":"2021","source":"Journal of pharmaceutical and biomedical analysis","url":"https://pubmed.ncbi.nlm.nih.gov/33989997","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35272502","id":"PMC_35272502","title":"Gene Therapy in Opn1mw Mice and Implications for Blue Cone Monochromacy Patients with Deletion Mutations.","date":"2022","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35272502","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2937147","id":"PMC_2937147","title":"Molecular genetics of human color vision: the genes encoding blue, green, and red pigments.","date":"1986","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2937147","citation_count":1221,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8185948","id":"PMC_8185948","title":"Molecular determinants of human red/green color discrimination.","date":"1994","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/8185948","citation_count":325,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"6140680","id":"PMC_6140680","title":"Human visual pigments: microspectrophotometric results from the eyes of seven persons.","date":"1983","source":"Proceedings of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/6140680","citation_count":248,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3303660","id":"PMC_3303660","title":"Molecular biology of the visual pigments.","date":"1986","source":"Vision research","url":"https://pubmed.ncbi.nlm.nih.gov/3303660","citation_count":237,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7643192","id":"PMC_7643192","title":"Rod photoreceptor neurite sprouting in retinitis pigmentosa.","date":"1995","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/7643192","citation_count":197,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8857542","id":"PMC_8857542","title":"Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8857542","citation_count":186,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12853434","id":"PMC_12853434","title":"GRK1-dependent phosphorylation of S and M opsins and their binding to cone arrestin during cone phototransduction in the mouse retina.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12853434","citation_count":103,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23139274","id":"PMC_23139274","title":"The effect of cone opsin mutations on retinal structure and the integrity of the photoreceptor mosaic.","date":"2012","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/23139274","citation_count":80,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10319869","id":"PMC_10319869","title":"Position of a 'green-red' hybrid gene in the visual pigment array determines colour-vision phenotype.","date":"1999","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10319869","citation_count":73,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19956635","id":"PMC_19956635","title":"Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19956635","citation_count":73,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1302020","id":"PMC_1302020","title":"Defective colour vision associated with a missense mutation in the human green visual pigment gene.","date":"1992","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1302020","citation_count":71,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22888021","id":"PMC_22888021","title":"G protein-coupled receptors participate in cytokinesis.","date":"2012","source":"Cytoskeleton (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/22888021","citation_count":60,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2574415","id":"PMC_2574415","title":"Analysis of fusion gene and encoded photopigment of colour-blind humans.","date":"1989","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2574415","citation_count":53,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20579627","id":"PMC_20579627","title":"X-linked cone dystrophy caused by mutation of the red and green cone opsins.","date":"2010","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20579627","citation_count":41,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20220053","id":"PMC_20220053","title":"Variable retinal phenotypes caused by mutations in the X-linked photopigment gene array.","date":"2010","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/20220053","citation_count":39,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19386593","id":"PMC_19386593","title":"The action of 11-cis-retinol on cone opsins and intact cone photoreceptors.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19386593","citation_count":34,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12051694","id":"PMC_12051694","title":"Novel missense mutations in red/green opsin genes in congenital color-vision deficiencies.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12051694","citation_count":33,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27447086","id":"PMC_27447086","title":"Cone Photoreceptor Structure in Patients With X-Linked Cone Dysfunction and Red-Green Color Vision Deficiency.","date":"2016","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/27447086","citation_count":33,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29386880","id":"PMC_29386880","title":"Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy.","date":"2018","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/29386880","citation_count":25,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9494086","id":"PMC_9494086","title":"Large-scale production and purification of the human green cone pigment: characterization of late photo-intermediates.","date":"1998","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/9494086","citation_count":22,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28045251","id":"PMC_28045251","title":"A G Protein-Coupled Receptor Dimerization Interface in Human Cone Opsins.","date":"2016","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28045251","citation_count":21,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8792812","id":"PMC_8792812","title":"A new mechanism in blue cone monochromatism.","date":"1996","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8792812","citation_count":21,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9815288","id":"PMC_9815288","title":"Regional expression of disease-related genes in human and monkey retina.","date":"1998","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/9815288","citation_count":21,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26387074","id":"PMC_26387074","title":"Beyond spectral tuning: human cone visual pigments adopt different transient conformations for chromophore regeneration.","date":"2015","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/26387074","citation_count":11,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16020309","id":"PMC_16020309","title":"Abnormal distribution of red/green cone opsins in a patient with an autosomal dominant cone dystrophy.","date":"2005","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16020309","citation_count":10,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29320632","id":"PMC_29320632","title":"Increasing the Stability of Recombinant Human Green Cone Pigment.","date":"2018","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29320632","citation_count":10,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35759666","id":"PMC_35759666","title":"The landscape of submicroscopic structural variants at the OPN1LW/OPN1MW gene cluster on Xq28 underlying blue cone monochromacy.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35759666","citation_count":10,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30948514","id":"PMC_30948514","title":"Human red and green cone opsins are O-glycosylated at an N-terminal Ser/Thr-rich domain conserved in vertebrates.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30948514","citation_count":8,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49288,"output_tokens":1371,"usd":0.084214},"stage2":{"model":"claude-opus-4-6","input_tokens":4617,"output_tokens":1696,"usd":0.098227},"total_usd":0.533004,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":63268,"output_tokens":5843,"usd":0.138725},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":8445,"output_tokens":3960,"usd":0.211838}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2016,\n      \"finding\": \"Intrachromosomal gene conversion from OPN1MW to OPN1LW in the male germline can generate the pathogenic 'LIAVA' haplotype in exon 3, causing aberrant splicing (exon 3 skipping) and resulting in Blue Cone Monochromacy; nine of twelve OPN1LW/MW exon 3 haplotypes tested caused ≥20% aberrant splicing as assessed by semi-quantitative minigene splicing assay.\",\n      \"method\": \"Semi-quantitative minigene splicing assay; pedigree analysis demonstrating de novo gene conversion\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional splicing assay with multiple haplotypes tested, supported by pedigree-level demonstration of gene conversion mechanism\",\n      \"pmids\": [\"27339364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Diverse haplotypes of exon 3 of OPN1MW (and OPN1LW), arising through unequal recombination that intermixes the genes, cause exon 3-skipping during pre-mRNA splicing; the specific amino acid combination encoded by exon 3 determines whether the exonic splicing code is disrupted, linking particular haplotypes (e.g., 'LIAVA', 'LVAVA') to vision disorders including Blue Cone Monochromacy and cone dystrophy.\",\n      \"method\": \"Minigene splicing assays; molecular genetics analysis of recombinant haplotypes\",\n      \"journal\": \"Genes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mechanistic splicing assay replicated across multiple haplotypes, consistent with prior work, providing the molecular basis for disease\",\n      \"pmids\": [\"34440353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In Opn1mw−/− mice (M-opsin knockout), dorsal M-opsin dominant cone photoreceptors undergo outer segment degeneration but remain viable for at least 15 months; AAV5-mediated subretinal delivery of human L-opsin rescues cone outer segment structure and M-cone-mediated retinal function (ERG), demonstrating that OPN1MW protein expression is required for maintenance of cone outer segment integrity.\",\n      \"method\": \"AAV5 subretinal gene delivery; full-field ERG; immunohistochemistry; PNA staining in Opn1mw−/− mouse model\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo gene augmentation with functional and structural readouts in knockout model, multiple time points tested\",\n      \"pmids\": [\"31469404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"AAV-mediated expression of human L-opsin in Opn1mw−/− mice (lacking both M- and S-opsin) promotes cone outer segment regeneration and rescues cone-mediated function when administered at ≤2 months of age, establishing that OPN1MW/opsin expression is required for cone photoreceptor outer segment maintenance and that early intervention is critical; delayed treatment at 5–7 months yields significantly reduced rescue despite cone viability.\",\n      \"method\": \"AAV subretinal gene therapy; ERG; immunohistochemistry; visually guided behavior assays; proteasomal reporter (UbG76V-GFP) cross\",\n      \"journal\": \"Human gene therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo rescue experiment with multiple age cohorts, functional and structural endpoints, and genetic reporter to rule out alternative stress mechanisms\",\n      \"pmids\": [\"35272502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Long-read circular consensus sequencing combined with MLPA copy number analysis can resolve the complex structural variants (deletions, hybrid genes, single nucleotide variants) in the OPN1LW/OPN1MW gene cluster, demonstrating that the cluster's pathogenic diversity arises from both copy number changes and specific exonic haplotypes that affect splicing.\",\n      \"method\": \"Long-read CCS (circular consensus sequencing); MLPA; diagnostic validation on 50 clinical samples\",\n      \"journal\": \"NPJ genomic medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — diagnostic assay with clinical validation; primarily a technical/structural characterization rather than a direct functional mechanism study\",\n      \"pmids\": [\"36351915\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"OPN1MW encodes the middle-wavelength (green) cone photopigment opsin; its expression is required for cone outer segment integrity and M-cone phototransduction, and pathogenic loss-of-function arises predominantly through unequal recombination events that generate hybrid OPN1LW/OPN1MW genes carrying exon 3 haplotypes (e.g., 'LIAVA', 'LVAVA') that disrupt the exonic splicing code, causing exon 3 skipping and absent or severely reduced functional opsin protein, leading to Blue Cone Monochromacy and related cone dysfunction disorders.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEPT papers.\n\n**Classification:**\n- Papers about OPN1MW (middle-wavelength/green cone opsin): KEEP\n- Papers about CBD (cannabidiol), GCP-2/CXCL6 chemokine, GCP-WD/NEDD1 (microtubule nucleation), RubisCO cbbM, genistein combined polysaccharide, cellulose-binding domain, etc.: EXCLUDE (alias collisions)\n\n**KEPT papers** (from retrieved corpus + gene2pubmed):\n- PMID:27339364 (OPN1MW/OPN1LW gene conversion, BCM)\n- PMID:34440353 (OPN1LW/OPN1MW splicing disorders)\n- PMID:36351915 (OPN1LW/OPN1MW diagnostic analysis)\n- PMID:31469404 (Opn1mw-/- mice, gene therapy)\n- PMID:35272502 (Opn1mw mice, gene therapy)\n- PMID:35759666 (OPN1LW/OPN1MW structural variants, BCM)\n- PMID:2937147 (Nathans 1986 - molecular genetics of color vision pigments)\n- PMID:8185948 (Asenjo 1994 - spectral tuning determinants)\n- PMID:6140680 (Dartnall 1983 - microspectrophotometry)\n- PMID:8857542 (Ferreira 1996 - RanBP2 chaperone for red/green opsin)\n- PMID:12853434 (Zhu 2003 - GRK1 phosphorylation of cone opsins)\n- PMID:23139274 (Carroll 2012 - cone opsin mutations, retinal structure)\n- PMID:10319869 (Hayashi 1999 - hybrid gene position and color vision)\n- PMID:1302020 (Winderickx 1992 - C203R mutation)\n- PMID:2574415 (Neitz 1989 - fusion gene and pigment spectral properties)\n- PMID:20579627 (Gardner 2010 - X-linked cone dystrophy, W177R)\n- PMID:20220053 (Mizrahi-Meissonnier 2010 - variable retinal phenotypes)\n- PMID:19386593 (Ala-Laurila 2009 - 11-cis-retinol on cone opsins)\n- PMID:12051694 (Ueyama 2002 - missense mutations in red/green opsin)\n- PMID:27447086 (Patterson 2016 - cone structure with L/M opsin mutations)\n- PMID:29386880 (Deng 2018 - human L- and M-opsins restore M-cone function)\n- PMID:9494086 (Vissers 1998 - human green cone pigment photo-intermediates)\n- PMID:28045251 (Jastrzebska 2016 - GPCR dimerization interface in cone opsins)\n- PMID:26387074 (Srinivasan 2015 - cone opsin regeneration mechanism)\n- PMID:8792812 (Ladekjaer-Mikkelsen 1996 - BCM new mechanism)\n- PMID:9815288 (Bernstein 1998 - regional expression of disease-related genes)\n- PMID:16020309 (Bonilha 2005 - abnormal distribution of red/green opsins)\n- PMID:30948514 (Salom 2019 - O-glycosylation of red/green cone opsins)\n- PMID:29320632 (Owen 2018 - stability of recombinant green cone pigment)\n- PMID:12477932 (Strausberg 2002 - MGC cDNA sequences - no mechanistic finding)\n- PMID:21873635 (Gaudet 2011 - GO annotations - no mechanistic finding)\n- PMID:7643192 (Li 1995 - rod neurite sprouting - not about OPN1MW specifically)\n- PMID:3303660 (Applebury 1986 - molecular biology of visual pigments - review)\n- PMID:19956635 (Holmes 2009 - pharmacogenetics review - EXCLUDE)\n- PMID:22888021 (Zhang 2012 - GPCRs in cytokinesis - not OPN1MW specific)\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1986,\n      \"finding\": \"OPN1MW (green cone opsin) gene was isolated and sequenced from the human X chromosome (Xq28), revealing it is arranged in a head-to-tail tandem array with the red opsin gene. The deduced amino acid sequence shows 96% identity with red opsin and 43% identity with blue opsin, establishing the molecular basis of human trichromatic color vision.\",\n      \"method\": \"Genomic and cDNA cloning, DNA sequencing, Southern blotting\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original molecular cloning and sequencing study, foundational and widely replicated\",\n      \"pmids\": [\"2937147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"The green cone photoreceptor (M-cone) visual pigment was characterized by microspectrophotometry, establishing an absorption maximum of approximately 530.8 nm (with evidence for a bimodal sub-population distribution at ~533.7 and ~527.8 nm) in human foveal and parafoveal retina.\",\n      \"method\": \"Microspectrophotometry of human cone outer segments\",\n      \"journal\": \"Proceedings of the Royal Society of London. Series B\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro spectroscopic measurement of photopigment absorption in isolated human photoreceptors\",\n      \"pmids\": [\"6140680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"A fusion gene derived from recombination between OPN1LW and OPN1MW was sequenced and its encoded photopigment characterized spectroscopically; the pigment encoded by this hybrid gene absorbed light similar to normal M-cone (green) pigment (~530 nm) despite containing coding sequence from both genes, directly linking gene structure to pigment spectral properties.\",\n      \"method\": \"DNA sequencing of fusion gene, pigment spectroscopy\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct correlation of gene sequence with measured spectral properties of expressed pigment\",\n      \"pmids\": [\"2574415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The spectral difference (31 nm) between human red (OPN1LW) and green (OPN1MW) cone opsins is determined by exactly 7 amino acid residues (positions 116, 180, 230, 233, 277, 285, and 309), identified through an extensive mutagenesis study of 28 chimeric proteins and 30 point mutants. Replacing these residues converts red-to-green pigment spectral properties.\",\n      \"method\": \"Site-directed mutagenesis, expression of chimeric and point-mutant opsins, spectroscopic characterization\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis and spectroscopic validation, large systematic study\",\n      \"pmids\": [\"8185948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"RanBP2, a large cyclophilin-related protein (containing Ran-binding domain 4 [RBD4] and cyclophilin domains), acts as a molecular chaperone specifically for red/green (L/M) opsin in cone photoreceptors. The cyclophilin domain augments and stabilizes the interaction between red/green opsin and RBD4, possibly via proline isomerization, but does not bind opsin directly.\",\n      \"method\": \"Biochemical binding assays, domain dissection, functional chaperone assays in Drosophila/vertebrate systems\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — identification of binding partner with mechanistic follow-up (domain dissection, cyclophilin activity), replicated across systems\",\n      \"pmids\": [\"8857542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The human green cone pigment (OPN1MW) was functionally expressed in large-scale Sf9 insect cell cultures using recombinant baculovirus and purified via immobilized metal affinity chromatography. The purified pigment activated rod G-protein transducin at about half the rate of rhodopsin. Photo-intermediate analysis (Meta I, Meta II, Meta III) revealed the Meta I–Meta II equilibrium lacks pH dependence (unlike rod pigment), and the rate of Meta II decay was significantly faster than in rhodopsin.\",\n      \"method\": \"Recombinant expression in Sf9 cells, immobilized metal affinity chromatography purification, UV-Vis spectroscopy, G-protein activation assay, lipid reconstitution\",\n      \"journal\": \"The Biochemical Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with functional assay and spectroscopic characterization of photo-intermediates\",\n      \"pmids\": [\"9494086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The position of a green-red hybrid gene within the OPN1LW/OPN1MW tandem array determines color vision phenotype: the hybrid gene causes deuteranomaly only when it occupies the second position (where it is expressed), and does not cause color vision defects when it is in the third or more distal position (where it is not expressed). mRNA expression analysis confirmed position-dependent expression.\",\n      \"method\": \"Long-range PCR, gene sequencing, mRNA expression analysis in post-mortem retinae\",\n      \"journal\": \"Nature Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct demonstration of position-dependent gene expression from post-mortem human retinae, consistent with clinical phenotyping\",\n      \"pmids\": [\"10319869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GRK1 (G protein-coupled receptor kinase 1) phosphorylates light-activated M-cone opsin (OPN1MW) at multiple sites in a light-dependent manner in mouse retina. Following phosphorylation, cone arrestin (mCAR) binds to the phosphorylated, light-activated M-cone opsin, quenching phototransduction. In Nrl−/−Grk1−/− double-knockout mice, cone opsins are neither phosphorylated nor bound by cone arrestin.\",\n      \"method\": \"In situ phosphorylation, isoelectric focusing, immunoprecipitation with cone opsin and cone arrestin antibodies, genetic knockout mouse models\",\n      \"journal\": \"The Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal immunoprecipitation, confirmed by genetic epistasis (double KO), multiple orthogonal methods\",\n      \"pmids\": [\"12853434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"11-cis-retinol acts as an inverse agonist on expressed human green cone opsin (OPN1MW), inactivating its constitutive activity (measured as transducin activation). It also promotes pigment formation (chromophore binding) in salamander cone photoreceptors, supporting a distinct retinoid handling mechanism in cones compared to rods.\",\n      \"method\": \"Cell-free transducin activation assay (GTPγS incorporation), microspectrophotometry of isolated photoreceptors, comparative pharmacology\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution assay with expressed opsin, confirmed by microspectrophotometry in isolated photoreceptors\",\n      \"pmids\": [\"19386593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Three novel missense mutations in OPN1MW (Asn94Lys) and OPN1LW (Arg330Gln, Gly338Glu) cause red/green color vision deficiencies by disrupting visual pigment formation: Asn94Lys and Gly338Glu mutations abolish all detectable absorbance (loss of pigment), while Arg330Gln yields a low-absorbance pigment with λmax of 530 nm, indicating these mutations impair protein folding required for chromophore binding.\",\n      \"method\": \"Mutation identification by DNA sequencing, expression of mutant opsins in COS-7 cells, reconstitution with 11-cis-retinal, UV-Vis spectrophotometry\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — expression and spectroscopic characterization of mutant opsins with defined functional consequences\",\n      \"pmids\": [\"12051694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"A missense mutation in OPN1MW (C203R, cysteine to arginine at position 203) causes severe deuteranomaly (green color vision deficiency). This conserved cysteine is necessary for normal green opsin function, presumably for correct protein folding.\",\n      \"method\": \"DNA sequencing, clinical color vision phenotyping\",\n      \"journal\": \"Nature Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct mutation identification with clinical phenotypic consequence, but mechanistic basis inferred rather than directly tested in vitro\",\n      \"pmids\": [\"1302020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The W177R missense mutation affecting OPN1MW (arising by gene conversion making both opsin genes identical to the MW sequence) causes protein misfolding and retention in the endoplasmic reticulum, leading to X-linked cone dystrophy. Unlike the P23H rod opsin mutation, W177R misfolding is not rescued by pharmacological chaperone 9-cis-retinal.\",\n      \"method\": \"Molecular genetic analysis, cell-based expression with ER localization assay, pharmacological chaperone treatment assay\",\n      \"journal\": \"American Journal of Human Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cellular mechanistic assay (ER retention) combined with pharmacological chaperone rescue experiment, clear molecular mechanism established\",\n      \"pmids\": [\"20579627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Human green cone opsin (OPN1MW) and red cone opsin (OPN1LW) adopt different transient conformations during chromophore regeneration: photoactivated green cone opsin regenerates via an unprotonated Schiff base intermediate, whereas red cone opsin forms a typical protonated Schiff base. Site-directed mutagenesis and molecular modeling identified structural differences in the photoactivated state between the two pigments.\",\n      \"method\": \"UV-Vis and fluorescence spectroscopy, site-directed mutagenesis, molecular modeling\",\n      \"journal\": \"Cellular and Molecular Life Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro spectroscopic and mutagenesis study with molecular modeling, single lab\",\n      \"pmids\": [\"26387074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Human red cone opsin (OPN1LW) exhibits a strong propensity for dimerization via a specific interface in the fifth transmembrane helix involving residues I230, A233, and M236, identified by mutagenesis. Green cone opsin (OPN1MW) does not dimerize strongly. Notably, the same residues (I230, A233) responsible for red opsin dimerization are also partially responsible for spectral tuning differences between red and green opsins.\",\n      \"method\": \"Time-resolved fluorescence (measuring dimerization affinity), site-directed mutagenesis, spectroscopic analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — biophysical measurement of dimerization with mutagenesis confirmation and functional (spectral tuning) link, multiple orthogonal methods\",\n      \"pmids\": [\"28045251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Human red and green cone opsins (OPN1LW and OPN1MW) are O-glycosylated at a conserved N-terminal Ser/Thr-rich domain (at Ser22 in bovine OPSR) in addition to N-glycosylation at Asn34. This O-glycosylation is conserved across vertebrates (mammals, birds, amphibians), as demonstrated by jacalin lectin binding, O-glycosidase treatment revealing the underlying epitope, and mass spectrometry identifying O-glycan on Ser22.\",\n      \"method\": \"Monoclonal antibody recognition assay, O-glycosidase treatment, jacalin lectin binding, mass spectrometry, cross-species analysis\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (antibody, lectin, MS, enzymatic treatment) identifying post-translational modification in native human retinal tissue\",\n      \"pmids\": [\"30948514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Specific exon 3 haplotypes of OPN1MW (e.g., 'LIAVA', 'LVAVA') cause exon 3 skipping during pre-mRNA splicing, abolishing or severely reducing correctly spliced transcripts, leading to vision disorders including Blue Cone Monochromacy. Intrachromosomal gene conversion between OPN1LW and OPN1MW in the male germline was demonstrated to generate pathogenic haplotypes de novo (e.g., 'LIAVA' from ancestral 'LIAVS').\",\n      \"method\": \"Semi-quantitative minigene splicing assay, molecular haplotyping, pedigree analysis demonstrating de novo gene conversion\",\n      \"journal\": \"Genes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional splicing assay with multiple haplotypes tested, combined with pedigree-level demonstration of gene conversion mechanism\",\n      \"pmids\": [\"34440353\", \"27339364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"AAV5-mediated subretinal delivery of human OPN1MW or OPN1LW into Opn1mw−/− mice (M-opsin knockout model of Blue Cone Monochromacy) promotes regrowth of cone outer segments in the dorsal retina and rescues M-cone-mediated ERG function. Both M- and L-opsin constructs are effective, and rescue is maintained for at least 13 months post-injection.\",\n      \"method\": \"Subretinal AAV5 gene delivery, electroretinography (ERG), immunohistochemistry, western blotting\",\n      \"journal\": \"Molecular Vision\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gene therapy rescue experiment with multiple functional and structural readouts\",\n      \"pmids\": [\"29386880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"AAV5-mediated L-opsin gene therapy can rescue M-cone function and outer segment structure in aged Opn1mw−/− mice (up to 15 months old), demonstrating that the remaining viable cones retain the capacity to respond to opsin gene delivery even at advanced age, though cone outer segment degeneration begins early and ventral S-opsin-dominant cones remain normal.\",\n      \"method\": \"Subretinal AAV5 injection, electroretinography, PNA staining for cone quantification, immunohistochemistry\",\n      \"journal\": \"Investigative Ophthalmology & Visual Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gene therapy with functional and structural outcomes across multiple ages\",\n      \"pmids\": [\"31469404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Gene augmentation therapy with AAV-mediated human L-opsin delivery rescues cone outer segment structure and function in Opn1mw−/− mice (lacking both M- and S-opsin, a more stringent BCM model), but only when delivered at 2 months of age or younger; therapeutic efficacy is significantly reduced at 5–7 months. Impaired proteasomal activity was excluded as a contributing stress factor in cone degeneration.\",\n      \"method\": \"Subretinal AAV injection, ERG, immunohistochemistry, crossing with proteasomal reporter mouse (UbG76V-GFP)\",\n      \"journal\": \"Human Gene Therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gene therapy with defined therapeutic window and mechanistic exclusion experiment\",\n      \"pmids\": [\"35272502\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"OPN1MW encodes the human M-cone (green) visual pigment, a GPCR localized in cone outer segments whose 530 nm absorption maximum is determined by 7 specific amino acid residues differentiating it from red opsin; after light activation, it is phosphorylated by GRK1 and bound by cone arrestin to terminate phototransduction, undergoes regeneration via an unprotonated Schiff base intermediate (distinct from red opsin), is O-glycosylated at a conserved N-terminal Ser/Thr domain, is chaperoned by the RanBP2 cyclophilin domain for proper folding, and pathogenic exon 3 haplotypes or missense mutations (e.g., W177R causing ER retention, C203R, Asn94Lys) that disrupt splicing or protein folding cause a spectrum of color vision deficiency to progressive cone dystrophy, which can be rescued in mouse models by AAV-mediated opsin gene delivery.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"OPN1MW encodes the middle-wavelength-sensitive (green) cone opsin, a G-protein-coupled photopigment essential for M-cone phototransduction and maintenance of cone outer segment structure; loss of functional OPN1MW protein in Opn1mw−/− mice causes outer segment degeneration that is rescued by AAV-mediated opsin gene delivery, with efficacy dependent on early intervention [PMID:31469404, PMID:35272502]. Pathogenic loss of function arises predominantly through unequal recombination and intrachromosomal gene conversion between OPN1LW and OPN1MW, generating hybrid genes whose exon 3 haplotypes (e.g., 'LIAVA', 'LVAVA') disrupt the exonic splicing code, causing exon 3 skipping and absence of functional opsin protein [PMID:27339364, PMID:34440353]. These splicing-defective haplotypes are the principal molecular basis of Blue Cone Monochromacy and related cone dysfunction disorders [PMID:34440353].\",\n  \"teleology\": [\n    {\n      \"year\": 2016,\n      \"claim\": \"Establishing how specific exon 3 haplotypes disrupt splicing resolved the molecular link between OPN1LW/MW recombination events and cone disease: intrachromosomal gene conversion generates the pathogenic 'LIAVA' haplotype, and nine of twelve tested haplotypes cause ≥20% aberrant exon 3 skipping.\",\n      \"evidence\": \"Semi-quantitative minigene splicing assay with twelve exon 3 haplotypes; pedigree analysis demonstrating de novo gene conversion\",\n      \"pmids\": [\"27339364\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Splicing effects measured in minigene system, not in native cone photoreceptors\",\n        \"Quantitative thresholds of exon skipping required to produce clinical disease are unknown\",\n        \"Whether gene conversion frequency differs across populations is uncharacterized\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating that M-opsin knockout causes outer segment degeneration while cones remain viable, and that AAV-delivered L-opsin rescues both structure and function, established that OPN1MW protein itself is required for cone outer segment maintenance beyond its role in phototransduction.\",\n      \"evidence\": \"AAV5 subretinal gene delivery of human L-opsin in Opn1mw−/− mice; full-field ERG, immunohistochemistry, and PNA staining over multiple time points\",\n      \"pmids\": [\"31469404\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which opsin absence leads to outer segment degeneration (protein trafficking vs. disc biogenesis failure) is unresolved\",\n        \"Whether human M-cone degeneration follows the same time course as in the mouse model is unknown\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Systematic splicing analysis across diverse recombinant OPN1LW/MW exon 3 haplotypes confirmed that the specific amino acid combination encoded by exon 3 determines whether the exonic splicing code is disrupted, generalizing the pathogenic mechanism beyond the LIAVA haplotype.\",\n      \"evidence\": \"Minigene splicing assays with expanded haplotype panel; molecular genetics analysis of recombinant haplotypes\",\n      \"pmids\": [\"34440353\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"cis-regulatory elements outside exon 3 that may modulate splicing efficiency are uncharacterized\",\n        \"No structural model explains how amino acid identity in exon 3 alters splice site recognition\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defining a critical therapeutic window showed that early AAV-mediated opsin delivery (≤2 months) rescues cone outer segments and function in Opn1mw−/− mice, whereas delayed treatment yields markedly reduced rescue despite cone survival, establishing that progressive cellular changes limit treatability.\",\n      \"evidence\": \"AAV subretinal gene therapy in Opn1mw−/− mice at multiple ages; ERG, immunohistochemistry, visually guided behavior, and UbG76V-GFP proteasomal reporter cross\",\n      \"pmids\": [\"35272502\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The cellular process that renders cones refractory to late rescue (e.g., cytoskeletal remodeling, epigenetic silencing) is unidentified\",\n        \"Proteasomal stress was ruled out as the limiting factor, but alternative degenerative pathways remain untested\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Long-read sequencing resolved the full structural complexity of the OPN1LW/MW gene cluster, demonstrating that pathogenic diversity arises from both copy number changes and specific exonic haplotypes.\",\n      \"evidence\": \"Long-read circular consensus sequencing combined with MLPA on 50 clinical samples\",\n      \"pmids\": [\"36351915\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Primarily a diagnostic/structural characterization; functional consequences of newly identified structural variants require splicing and expression assays\",\n        \"Genotype–phenotype correlations for rare cluster configurations are incomplete\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis by which exon 3 amino acid identity controls exonic splicing enhancer/silencer activity, and the cellular mechanism linking opsin absence to outer segment degeneration (independent of phototransduction), remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structural or biochemical model explains how exon 3 coding variants alter splicing factor binding\",\n        \"The cone-intrinsic pathway from opsin loss to outer segment degeneration has not been delineated\",\n        \"Efficacy and therapeutic window of gene therapy in human Blue Cone Monochromacy patients are untested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"OPN1MW encodes the medium-wave-sensitive (green) cone opsin, a G protein-coupled receptor that initiates phototransduction in M-cones with an absorption maximum near 530 nm, underpinning trichromatic color vision [PMID:6140680, PMID:2937147]. The spectral difference between OPN1MW and the red opsin OPN1LW is determined by seven amino acid residues (positions 116, 180, 230, 233, 277, 285, 309), and OPN1MW is distinguished biophysically by regeneration through an unprotonated Schiff base intermediate, faster Meta II decay, and weak dimerization propensity [PMID:8185948, PMID:26387074, PMID:28045251, PMID:9494086]. Light-activated OPN1MW is phosphorylated by GRK1 and subsequently bound by cone arrestin to terminate signaling, is chaperoned by the RanBP2 cyclophilin domain for proper folding, and carries a conserved O-glycosylation at an N-terminal Ser/Thr domain [PMID:12853434, PMID:8857542, PMID:30948514]. Pathogenic exon 3 haplotypes (e.g., LIAVA/LVAVA) cause exon-skipping and Blue Cone Monochromacy, while missense mutations such as W177R cause ER retention and progressive cone dystrophy; AAV-mediated opsin gene delivery rescues cone structure and function in M-opsin knockout mouse models [PMID:34440353, PMID:20579627, PMID:29386880].\",\n  \"teleology\": [\n    {\n      \"year\": 1983,\n      \"claim\": \"Before the gene was cloned, the spectral identity of the M-cone pigment was established by directly measuring an ~530 nm absorption maximum in human foveal cone outer segments, defining the physical property that OPN1MW must encode.\",\n      \"evidence\": \"Microspectrophotometry of isolated human cone photoreceptors\",\n      \"pmids\": [\"6140680\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Bimodal sub-population (527.8 vs 533.7 nm) not fully explained\", \"Molecular basis of spectral tuning unknown at this stage\"]\n    },\n    {\n      \"year\": 1986,\n      \"claim\": \"Cloning OPN1MW from Xq28 revealed its tandem arrangement with OPN1LW and 96% amino acid identity, establishing the molecular genetic basis of green–red color discrimination and explaining the high frequency of recombination-driven color vision defects.\",\n      \"evidence\": \"Genomic/cDNA cloning and sequencing, Southern blotting\",\n      \"pmids\": [\"2937147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which specific residues drive spectral tuning not yet identified\", \"Expression regulation within the tandem array unknown\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Characterization of a naturally occurring OPN1LW–OPN1MW fusion gene showed that hybrid gene structure directly determines pigment spectral properties, providing the first genotype-to-phenotype link for color vision variation.\",\n      \"evidence\": \"DNA sequencing of fusion gene combined with pigment spectroscopy\",\n      \"pmids\": [\"2574415\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual spectral-tuning residues not resolved\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Identification of the C203R missense mutation as a cause of severe deuteranomaly established that a single residue change in OPN1MW is sufficient to abolish green cone function, implicating a conserved disulfide bond in protein folding.\",\n      \"evidence\": \"DNA sequencing with clinical color vision phenotyping in affected individuals\",\n      \"pmids\": [\"1302020\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vitro expression or spectroscopic confirmation of C203R at this stage\", \"Mechanism of folding defect inferred from conservation rather than demonstrated\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Systematic mutagenesis resolved the spectral tuning code to exactly seven amino acid positions, answering a decade-long question about which residues account for the 31 nm red–green shift and enabling prediction of hybrid gene phenotypes.\",\n      \"evidence\": \"28 chimeric and 30 point-mutant opsins expressed and characterized by UV-Vis spectroscopy\",\n      \"pmids\": [\"8185948\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural mechanism by which each residue shifts absorption not determined\", \"In vivo validation of all positions not performed\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Discovery that the RanBP2 cyclophilin domain acts as a specific molecular chaperone for L/M opsins revealed a post-translational folding requirement unique to cone pigments and explained why mutations disrupting folding are particularly pathogenic.\",\n      \"evidence\": \"Biochemical binding assays and domain dissection across Drosophila and vertebrate systems\",\n      \"pmids\": [\"8857542\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RanBP2 chaperoning involves proline isomerization in vivo unresolved\", \"Stoichiometry and kinetics of the chaperone interaction unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Purification and functional reconstitution of recombinant OPN1MW demonstrated that it activates transducin at roughly half the rate of rhodopsin and exhibits distinct photo-intermediate kinetics (pH-independent Meta I–Meta II equilibrium, faster Meta II decay), establishing core differences between cone and rod signaling.\",\n      \"evidence\": \"Baculovirus expression in Sf9 cells, affinity purification, UV-Vis spectroscopy, GTPγS-based transducin activation assay\",\n      \"pmids\": [\"9494086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Lipid-dependence of photo-intermediate kinetics not fully characterized\", \"Comparison to OPN1LW under identical conditions not reported\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Position-dependent expression within the tandem array was demonstrated: only the first or second gene copy is transcribed, explaining why the same hybrid gene causes deuteranomaly in one array position but is phenotypically silent in more distal positions.\",\n      \"evidence\": \"Long-range PCR with mRNA expression analysis in post-mortem human retinae\",\n      \"pmids\": [\"10319869\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Locus control region mechanism not fully elucidated\", \"Whether position-dependence is absolute or probabilistic unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Functional expression of disease-associated missense mutants (Asn94Lys in OPN1MW; Arg330Gln, Gly338Glu in OPN1LW) demonstrated that color vision deficiency can arise from complete loss of chromophore binding due to misfolding, not only from spectral shifts.\",\n      \"evidence\": \"Expression in COS-7 cells, reconstitution with 11-cis-retinal, UV-Vis spectrophotometry\",\n      \"pmids\": [\"12051694\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Folding intermediate trapped by each mutation not characterized\", \"Whether pharmacological rescue is possible not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstration that GRK1 phosphorylates light-activated M-cone opsin and that cone arrestin binds the phosphorylated pigment established the canonical desensitization pathway for M-cones, paralleling but distinct from the rod cascade.\",\n      \"evidence\": \"In situ phosphorylation, isoelectric focusing, immunoprecipitation in Nrl−/−Grk1−/− double-knockout mice\",\n      \"pmids\": [\"12853434\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact phosphorylation sites on OPN1MW not mapped\", \"Whether GRK7 contributes in human cones not addressed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"11-cis-retinol was shown to act as an inverse agonist of OPN1MW, suppressing constitutive transducin activation and promoting chromophore binding in cones, revealing a retinoid-handling mechanism absent in rods.\",\n      \"evidence\": \"Cell-free GTPγS incorporation assay with expressed green opsin, microspectrophotometry of salamander cones\",\n      \"pmids\": [\"19386593\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of inverse agonism in intact human cones not demonstrated\", \"Source and trafficking of 11-cis-retinol in the cone-Müller cell cycle not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The W177R mutation was shown to cause ER retention and misfolding-driven cone dystrophy that is refractory to 9-cis-retinal pharmacological chaperone rescue, distinguishing this pathogenic mechanism from the rescuable P23H rhodopsin mutation and highlighting the severity of M-opsin folding mutations.\",\n      \"evidence\": \"Cell-based expression with ER localization and pharmacological chaperone rescue assays\",\n      \"pmids\": [\"20579627\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for why W177R is unrescuable not determined\", \"Whether other chaperone strategies could rescue W177R untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Discovery that OPN1MW regenerates via an unprotonated Schiff base intermediate, unlike OPN1LW which uses a protonated intermediate, identified a fundamental mechanistic difference between the two highly similar cone pigments and implicated specific structural divergences in the photoactivated state.\",\n      \"evidence\": \"UV-Vis and fluorescence spectroscopy, site-directed mutagenesis, molecular modeling\",\n      \"pmids\": [\"26387074\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab observation not yet independently confirmed\", \"Crystal or cryo-EM structure of the intermediate not available\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Biophysical measurement showed OPN1MW has weak dimerization propensity compared to OPN1LW, and the dimerization interface residues (I230, A233, M236 in TM5) overlap with spectral-tuning sites, linking oligomerization state to spectral identity.\",\n      \"evidence\": \"Time-resolved fluorescence measuring dimerization affinity, site-directed mutagenesis\",\n      \"pmids\": [\"28045251\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo oligomeric state in cone outer segments not known\", \"Functional consequence of differing dimerization propensity on phototransduction not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Functional splicing assays established that specific exon 3 haplotypes (LIAVA, LVAVA) in OPN1MW cause exon 3 skipping, and pedigree analysis demonstrated that intrachromosomal gene conversion generates these pathogenic haplotypes de novo, providing a molecular mechanism for recurrent Blue Cone Monochromacy.\",\n      \"evidence\": \"Semi-quantitative minigene splicing assay, molecular haplotyping, pedigree analysis\",\n      \"pmids\": [\"34440353\", \"27339364\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Splicing regulatory elements mediating exon 3 skipping not identified\", \"Frequency of de novo gene conversion events in population not quantified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"AAV5-mediated delivery of human M- or L-opsin into M-opsin knockout mice rescued cone outer segment regrowth and ERG function for at least 13 months, providing the first proof-of-concept for gene therapy of Blue Cone Monochromacy.\",\n      \"evidence\": \"Subretinal AAV5 injection, ERG, immunohistochemistry, western blotting in Opn1mw−/− mice\",\n      \"pmids\": [\"29386880\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Optimal therapeutic window not defined\", \"Translation to primate retina not yet demonstrated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"O-glycosylation at a conserved N-terminal Ser/Thr domain was identified on human L/M opsins, revealing a previously unrecognized post-translational modification conserved across vertebrates whose functional role remains unknown.\",\n      \"evidence\": \"Monoclonal antibody recognition, O-glycosidase treatment, jacalin lectin binding, mass spectrometry on native human retina\",\n      \"pmids\": [\"30948514\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of O-glycosylation in opsin trafficking or stability not determined\", \"Glycosyltransferase responsible not identified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"A critical therapeutic window was defined: AAV-mediated opsin gene therapy rescues M-cone structure and function only when delivered by 2 months in Opn1mw−/− mice, with efficacy declining sharply thereafter, indicating that cone degeneration becomes irreversible and is not driven by proteasomal stress.\",\n      \"evidence\": \"Subretinal AAV injection at multiple ages, ERG, immunohistochemistry, proteasomal reporter mouse cross\",\n      \"pmids\": [\"35272502\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of irreversible cone loss beyond the window not identified\", \"Whether human cones have a comparably narrow window unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the high-resolution structure of OPN1MW (and its photo-intermediates), the functional significance of O-glycosylation and differential dimerization, the identity of splicing regulatory elements governing exon 3 inclusion, and the translational therapeutic window for gene therapy in human Blue Cone Monochromacy patients.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure of OPN1MW\", \"O-glycosylation function uncharacterized\", \"Therapeutic window in primate/human retina undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 3, 5, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 11]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0009709\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [1, 3, 5, 7, 8]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 7, 8]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [9, 10, 11, 15]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GRK1\",\n      \"ARR3\",\n      \"RANBP2\",\n      \"GNAT2\",\n      \"OPN1LW\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}